HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 70 filers reported holding HUMACYTE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,343,297 | +17.6% | 458,463 | +14.7% | 0.00% | – |
| Q2 2023 | $1,142,693 | -6.7% | 399,543 | +0.8% | 0.00% | – |
| Q1 2023 | $1,224,731 | +45.0% | 396,353 | -1.0% | 0.00% | – |
| Q4 2022 | $844,388 | -14.8% | 400,184 | +31.8% | 0.00% | – |
| Q3 2022 | $991,000 | -6.6% | 303,724 | -8.1% | 0.00% | – |
| Q2 2022 | $1,061,000 | -50.2% | 330,506 | +9.6% | 0.00% | -100.0% |
| Q1 2022 | $2,130,000 | -0.2% | 301,642 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $2,134,000 | – | 294,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |